Related Experiment Video
Updated: Jun 26, 2026

A Mouse Abdominal Aortic Aneurysm Model by Periadventitial Calcium Chloride and Elastase Infiltration
Published on: August 2, 2024
Coronary artery disease in patients with abdominal aortic aneurysm: a review article
J P Van Kuijk1, W J Flu, M Dunckelgrun
1Department of Anesthesiology, Erasmus Medical Centre, The Netherlands.
Insights
Abdominal aortic aneurysms (AAA) and coronary artery disease (CAD) share atherosclerosis but differ in prevalence, risk factors, and treatment outcomes. This review explores CAD characteristics in AAA patients, highlighting distinct pathophysiologies and risk profiles.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Epidemiology
Background:
- Abdominal aortic aneurysms (AAA) and coronary artery disease (CAD) were historically viewed as distinct vascular disorders with shared atherosclerotic origins.
- Emerging evidence indicates significant differences in prevalence, risk profiles (gender, age, diabetes mellitus), and independent progression despite CAD treatment.
- The stable prevalence of AAA contrasts with improved CAD outcomes, suggesting unique pathophysiological aspects.
Purpose of the Study:
- To review and discuss the epidemiological characteristics of CAD in patients with AAA.
- To elucidate the distinct and common pathophysiological pathways of AAA and CAD.
- To examine the role of preoperative CAD testing and the influence of combined AAA and CAD treatment on long-term outcomes.
Main Methods:
- Literature review focusing on epidemiological data, pathophysiology, risk profiles, diagnostic testing, and treatment strategies for AAA and CAD.
- Comparative analysis of AAA and CAD characteristics, including risk factors and cardiovascular event influence.
- Discussion of surgical and medical interventions for combined AAA and CAD management.
Main Results:
- AAA and CAD exhibit differing prevalence rates and risk factor profiles, particularly concerning gender, age, and diabetes.
- Despite advancements in CAD treatment, AAA prevalence remains unchanged, indicating distinct disease trajectories.
- Preoperative assessment for CAD in AAA patients is crucial due to the significant impact of CAD on adverse outcomes.
Conclusions:
- AAA and CAD, while sharing an atherosclerotic background, possess distinct epidemiological and pathophysiological characteristics.
- Understanding these differences is vital for optimizing preoperative risk stratification and management strategies in patients with both conditions.
- Combined treatment approaches for AAA and CAD require careful consideration to improve long-term patient outcomes.
Abstract:
Abdominal aortic aneurysms (AAA) and coronary artery disease (CAD) have traditionally been regarded as two separate vessel disorders with a common background. Atherosclerosis has always been considered as the basic pathophysiologic process. However, during the last decade, evidence has emerged with differences between AAA and CAD. Firstly, data regarding the prevalence of AAA and CAD are different. Secondly, the risk profiles between AAA and CAD differ, mainly regarding gender, age and diabetes mellitus. Thirdly, despite the intensive treatment of CAD and improved outcome, the prevalence of AAA has not changed during the last decade. In this review we will discuss the characteristics of CAD in patients with AAA. In the first part we focus on epidemiological data of CAD in AAA patients. The pathophysiology of both AAA and CAD will be described in the second part. There is a common pathway between pathophysiology and risk profiles that is discussed in the third chapter. Based on the presence of risk factors and their influence on cardiovascular events, the preoperative work-up and testing for CAD in AAA has gained an important role. The role of (non)-invasive testing will be described in the fourth chapter. The treatment of AAA traditionally consisted solely of surgery. However, due to the influence of CAD on adverse outcomes, medical intervention is potentially useful. Surgical approaches for the treatment of both AAA and CAD, and most importantly, their influence on long-term outcome will be discussed in the fifth chapter.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aneurysm I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aortic Regurgitation III: Medical Management

